The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Preimplantation Genetic Testing Market Expected To Scale Between 2026 And 2030?
The preimplantation genetic testing market has experienced significant expansion recently. Projections indicate its value will rise from $0.92 billion in 2025 to $1.03 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. Historically, this expansion has been driven by factors such as the rising adoption of assisted reproductive technologies, innovations in embryo biopsy procedures, heightened public knowledge regarding genetic disease avoidance, the proliferation of fertility clinics, and enhanced IVF success rates.
The preimplantation genetic testing market is projected for swift expansion in the coming years, reaching $1.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.1%. This anticipated growth during the forecast period is driven by several factors, including a heightened demand for tailored reproductive medicine, increased integration of sophisticated genomic technologies, broader availability of fertility preservation services, greater capital expenditure in reproductive health infrastructure, and wider regulatory approval of genetic screening. Key developments expected during this timeframe encompass a surge in embryo screening procedures, the growing application of next-generation sequencing in IVF, an extension of genetic testing within fertility treatments, a rising need for better implantation success rates, and a sharpened emphasis on mitigating genetic disorders.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp
What Key Factors Are Shaping The Preimplantation Genetic Testing Market Landscape?
The rising number of in vitro fertilization (IVF) procedures is expected to fuel the expansion of the preimplantation genetic testing market moving forward. IVF procedures involve fertilizing an egg with sperm outside the body to form an embryo, which is subsequently placed into the uterus. Growth in IVF procedures is influenced by progress in reproductive technology, an increase in infertility rates, and enhanced public awareness. The surge in in vitro fertilization (IVF) procedures is boosting the preimplantation genetic testing market by elevating the demand for genetic screening of embryos before implantation. For example, in June 2025, the Human Fertilisation & Embryology Authority, an independent UK-based regulator of fertility treatment, reported that in 2023, 52,400 patients underwent over 77,500 in vitro fertilization (IVF) cycles at licensed fertility clinics in the UK. Egg freezing cycles saw an increase from 4,700 in 2022 to 6,900 in 2023, making up 7% of all cycles. Therefore, the rise in in vitro fertilization (IVF) procedures is a key driver for the preimplantation genetic testing market.
How Is The Preimplantation Genetic Testing Market Segmented Across Different Segment Categories?
The preimplantation genetic testing market covered in this report is segmented –
1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs
Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation
What Market Trends Are Affecting The Preimplantation Genetic Testing Market?
Leading companies in the preimplantation genetic testing market are developing sophisticated next-generation sequencing (NGS) tools to enhance accuracy, efficiency, and speed in genetic screening, enabling more comprehensive analysis and better-informed decisions for prospective parents. Next-generation sequencing (NGS) tools accelerate genetic research with rapid, high-throughput analysis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). They provide detailed insights into genetic variations and gene expression, improving accuracy and facilitating personalized medicine. For instance, in July 2023, Thermo Fisher Scientific, a US-based biotechnology company, launched the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These advanced next-generation sequencing tools are specifically designed to enhance IVF and ICSI research. These assays streamline workflows from sample processing to aneuploidy analysis with cutting-edge technology on the Ion Torrent Genexus integrated sequencer, marking a significant advancement in the preimplantation genetic testing market by enhancing embryo screening and improving success rates in assisted reproductive technologies.
Which Organizations Play A Role In The Preimplantation Genetic Testing Market Landscape?
Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd, Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC
Get The Full Preimplantation Genetic Testing Market Report:
Which Region Leads The Preimplantation Genetic Testing Market In Terms Of Market Share?
North America was the largest region in the preimplantation genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Preimplantation Genetic Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Preimplantation Genetic Testing Market 2026, By The Business Research Company
Pediatric And Neonatal Testing Kit Market Report 2026
Ovulation Testing Kits Market Report
https://www.thebusinessresearchcompany.com/report/ovulation-testing-kits-global-market-report
Dna Test Kits Market Report
https://www.thebusinessresearchcompany.com/report/dna-test-kits-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model